Displaying 4151-4200 of 919967 result(s).
Recent Articles
- Neogen Investors Can Join a Securities Fraud Class Action
- Enhancing Skincare Access with HSA/FSA at Dermstore
- Jarlath Keating Takes Charge at Solvias Group USA for Growth
- Join Autodesk's Upcoming Financial Results Call and Learn More
- Simmons First National Corporation: Transitioning Leadership Ahead
- Microsoft Teams Partners with Thrive Global for Enhanced Wellbeing
- Chainlink Unveils Real-Time Data Streams for Financial Markets
- Leslie Donato Joins Mallinckrodt's Board to Enhance Leadership
- Five to Flow Unveils BurnoutIQ™: A Solution for Employee Well-Being
- Unlocking Carbon Capture: Your Majesty's Innovative Digital Shift
- U Power Partners with Tech Firm for 300 Battery-Swapping Vehicles
- BTC Digital Ltd. Announces Postponement for Upcoming Meeting
- Aura Minerals Implements Voluntary Delisting from Major Exchange
- Alveolus Bio's Innovative Partnership to Transform Pulmonary Care
- Innovative DC Power Supplies Enhance Panasonic TOUGHBOOKs
- Algorhythm's Strategic Shift: $4.5M Sale Opens New Horizons
- Celebrating Wellness: A Star-Studded Retreat Experience
- Streamlining Solar Installations: Enphase Energy's IQ Meter Collar
- José Molina Takes on CFO Role to Propel Canela Media Forward
- INmune Bio's Successful CaRe PC Trial Brings Hope for mCRPC
- Gardner White Launches Exciting Super Sale for Furniture Lovers
- Stingray Enhances Karaoke Portfolio with Strategic Acquisition
- NRx Pharmaceuticals Pushes for Benzethonium Chloride Removal
- Cerence AI Takes Action Against Sony and TCL for IP Infringement
- Coalfire Unveils DivisionHex for Advanced Cybersecurity Solutions
- CareCloud Secures Certification, Tapping Into $1.5B Inpatient Market
- Exciting New Franchise Opens in Historic Coastal City
- CPI Aero Secures $2.5 Million in Orders for T-38 Modification Kits
- NTAP Reimbursement Approval for Inflammatix's TriVerity Test Boosts Diagnostics
- LifeMD's Engagement at the Upcoming Growth Conference
- Cetera Connect2Peers 2025: Empowering Financial Professionals
- BioAtla's Upcoming Financial Announcement: What to Expect
- GTI Holding Sees Significant Growth in Key Market Sectors
- Bioventus Secures $400 Million Financing to Enhance Growth Strategy
- Freshworks Set to Shine at the Oppenheimer Tech Conference
- Strengthening Income Streams with Westwood ETFs MDST & WEEI
- Jefferson Capital Sets Stage for Q2 2025 Financial Reveal
- Greif, Inc. Shares Insights on Upcoming Q3 Earnings Call
- Xenon Pharmaceuticals to Announce Q2 Financial Results Soon
- VCI Global Unveils CyberSecure Vault to Boost Cyber Defense
- Catalyst Pharmaceuticals Welcomes Dr. Daniel Curran to Board
- Stardust Power Invites Investors to Q2 Earnings Call Soon
- Pioneering Solid Strategies: Artelo Biosciences' $9.475M Initiative
- Artelo Biosciences Launches $9.475 Million SOL Treasury Strategy
- Innovative Findings on Simufilam for Treating TSC-Related Seizures
- XOMA Royalty Moves to Acquire LAVA Therapeutics in Cash Deal
- Kura Oncology Expands Team with New Stock Option Grants
- Zevra Therapeutics Sets Stage for Q2 2025 Financial Update
- Zevra Therapeutics Sets Date for Q2 2025 Financial Results Call
- Court Case Update: Quantum BioPharma vs Major Banks